Table 1.
ALL cases |
Total N=270 |
Healthy subjects |
Total N=177* |
||||
---|---|---|---|---|---|---|---|
Admixed n= 176 |
Indigenous n= 84 |
Admixed n= 88 |
Indigenous n= 87 |
||||
| |||||||
Sex , (%) | |||||||
59.7 | 53.6 | 57.3 | 22.7 | 37.9 | 31.1 | ||
Male | 40.3 | 46.4 | 42.2 | 77.3 | 62.1 | 58.9 | |
Female | |||||||
| |||||||
Genotypes, (%) | |||||||
TPMT*1/ TPMT *2 | 1.1 | 0 | 0.7 | 3.4 | 0 | 1.7 | |
TPMT*1/ TPMT *3A | 7.5 | 7.1 | 7.4 | 11.4 | 9.2 | 10.2 | |
TPMT*3A/ TPMT *3A | 0 | 0 | 0 | 0 | 1.1 | 0.56 | |
TPMT*1/ TPMT *3B | 0 | 1.2 | 0.3 | 0 | 0 | 0 | |
TPMT*1/ TPMT *3C | 2.1 | 0 | 1.5 | 2.3 | 0 | 1.1 | |
Total | 10.7 | 8.3 | 10.0 | 16.9 | 10.3 | 13.6 | |
|
|||||||
P value | 0.67 | 0.41 | |||||
| |||||||
Allele frequency, (%) | |||||||
TPMT *2 | 0.55 | 0 | 0.035 | 1.7 | 0 | 0.8 | |
TPMT *3A | 3.75 | 3.6 | 3.7 | 5.7 | 5.7 | 5.7 | |
TPMT *3B | 0 | 0 | 0.015 | 0 | 0 | 0 | |
TPMT *3C | 1.05 | 0.6 | 0.75 | 1.1 | 0 | 0.6 | |
Total | 5.4 | 4.2 | 5.0 | 8.5 | 5.7 | 7.1 | |
|
|||||||
P value | 0.67 | 0.41 |